Semis Slide, Oil Climbs, Nike Results on Deck… And The Latest Use Case For GLP-1’s 3/30/26
A volatile day for stocks as memory-chip names reverse sharply and investors eye the latest developments in the Middle East — and why one top strategist says this week is “maximum uncertainty” with a key S&P level in focus. Plus, crude bounces higher as energy stays in the spotlight, banks try to stabilize but remain under pressure, and we look ahead to Nike earnings at near-decade lows. Eli Lilly pushes deeper into GLP-1s — including potential use in substance abuse — as investors track the next big catalyst in healthcare.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
More description
A volatile day for stocks as memory-chip names reverse sharply and investors eye the latest developments in the Middle East — and why one top strategist says this week is “maximum uncertainty” with a key S&P level in focus. Plus, crude bounces higher as energy stays in the spotlight, banks try to stabilize but remain under pressure, and we look ahead to Nike earnings at near-decade lows. Eli Lilly pushes deeper into GLP-1s — including potential use in substance abuse — as investors track the next big catalyst in healthcare.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Listen elsewhere
Available Results
Generated results are saved to your library for reuse and search.